Top Healthcare Stocks by Share Buybacks
Top healthcare companies ranked by share buybacks, latest annual filings.
What Share Buybacks Mean for Healthcare Companies
Share buybacks in healthcare cluster heavily at large pharma, managed care, and medical device firms with predictable cash generation. Developmental biotech, which consumes rather than produces cash, is effectively absent from this ranking. Large pharma typically combines buybacks with a substantial dividend, treating repurchases as the flexible layer on top of a committed payout, while managed-care operators lean on buybacks as their primary capital-return mechanism.
Why It Matters in Healthcare
Buyback programs at mature healthcare firms signal confidence in the existing franchise surviving patent cliffs or reimbursement resets. Yet a repurchase that coincides with a weakening pipeline can mask underlying erosion by lifting per-share earnings even as the underlying business softens. Read alongside R&D intensity and pipeline disclosure, buybacks tell a cleaner story about whether capital return is coming from surplus strength or from a shrinking investment budget.
What to Read Alongside
Pair buybacks with Free Cash Flow to confirm programs are genuinely self-funded, R&D Spending to see whether capital return trades off against pipeline investment, and Net Income for EPS context.
| # | Symbol | Company | Sector | ||
|---|---|---|---|---|---|
| 1 | HCA | HCA Healthcare, Inc. | Healthcare | $10.07B | $91.33B |
| 2 | NVS | Novartis AG | Healthcare | $9.12B | $261.31B |
| 3 | JNJ | Johnson & Johnson | Healthcare | $5.95B | $643.64B |
| 4 | UNH | UnitedHealth Group Incorporated | Healthcare | $5.54B | $352.81B |
| 5 | MRK | Merck & Co., Inc. | Healthcare | $5.08B | $363.98B |
| 6 | MCK | McKesson Corporation | Healthcare | $4.75B | $103.96B |
| 7 | LLY | Eli Lilly and Company | Healthcare | $4.11B | $1002.07B |
| 8 | CI | The Cigna Group | Healthcare | $3.62B | $73.50B |
| 9 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | $3.44B | $83.15B |
| 10 | ZTS | Zoetis Inc. | Healthcare | $3.23B | $30.29B |
| 11 | DHR | Danaher Corporation | Healthcare | $3.09B | $144.01B |
| 12 | TMO | Thermo Fisher Scientific Inc. | Healthcare | $3.00B | $223.95B |
| 13 | ELV | Elevance Health, Inc. | Healthcare | $2.60B | $86.08B |
| 14 | ISRG | Intuitive Surgical, Inc. | Healthcare | $2.30B | $124.79B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | $2.02B | $132.08B |
| 16 | GILD | Gilead Sciences, Inc. | Healthcare | $1.92B | $180.60B |
| 17 | THC | Tenet Healthcare Corporation | Healthcare | $1.39B | $21.67B |
| 18 | CAH | Cardinal Health, Inc. | Healthcare | $1.36B | $55.82B |
| 19 | DVA | DaVita Inc. | Healthcare | $1.31B | $11.68B |
| 20 | IQV | IQVIA Holdings Inc. | Healthcare | $1.24B | $42.30B |
| 21 | RPRX | Royalty Pharma plc | Healthcare | $1.23B | $26.98B |
| 22 | IDXX | IDEXX Laboratories, Inc. | Healthcare | $1.22B | $40.58B |
| 23 | MDT | Medtronic plc | Healthcare | $1.03B | $117.54B |
| 24 | BDX | Becton, Dickinson and Company | Healthcare | $1.00B | $48.98B |
| 25 | MOH | Molina Healthcare, Inc. | Healthcare | $1.00B | $10.13B |
| 26 | UTHR | United Therapeutics Corporation | Healthcare | $1.00B | $21.74B |
| 27 | ABBV | AbbVie Inc. | Healthcare | $0.98B | $443.39B |
| 28 | UHS | Universal Health Services, Inc. | Healthcare | $0.97B | $10.36B |
| 29 | EXEL | Exelixis, Inc. | Healthcare | $0.95B | $14.45B |
| 30 | MEDP | Medpace Holdings, Inc. | Healthcare | $0.92B | $16.36B |
| 31 | EW | Edwards Lifesciences Corporation | Healthcare | $0.89B | $49.67B |
| 32 | ABT | Abbott Laboratories | Healthcare | $0.89B | $182.09B |
| 33 | HSIC | Henry Schein, Inc. | Healthcare | $0.85B | $9.80B |
| 34 | RVTY | Revvity, Inc. | Healthcare | $0.82B | $13.82B |
| 35 | MTD | Mettler-Toledo International Inc. | Healthcare | $0.80B | $25.85B |
| 36 | HOLX | Hologic, Inc. | Healthcare | $0.75B | $16.97B |
| 37 | ICLR | ICON Public Limited Company | Healthcare | $0.75B | $12.31B |
| 38 | ILMN | Illumina, Inc. | Healthcare | $0.74B | $30.95B |
| 39 | RMD | ResMed Inc. | Healthcare | $0.70B | $31.73B |
| 40 | SNN | Smith & Nephew plc | Healthcare | $0.50B | $11.63B |
| 41 | VTRS | Viatris Inc. | Healthcare | $0.50B | $18.95B |
| 42 | DXCM | DexCom, Inc. | Healthcare | $0.50B | $31.65B |
| 43 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | $0.49B | $18.05B |
| 44 | CNC | Centene Corporation | Healthcare | $0.47B | $31.65B |
| 45 | ALGN | Align Technology, Inc. | Healthcare | $0.47B | $10.86B |
| 46 | DGX | Quest Diagnostics Incorporated | Healthcare | $0.45B | $25.99B |
| 47 | LH | Labcorp Holdings Inc. | Healthcare | $0.45B | $26.04B |
| 48 | COR | Cencora, Inc. | Healthcare | $0.44B | $61.70B |
| 49 | DOCS | Doximity, Inc. | Healthcare | $0.43B | $4.31B |
| 50 | CHE | Chemed Corporation | Healthcare | $0.43B | $6.78B |
| 51 | GMAB | Genmab A/S | Healthcare | $0.43B | $20.32B |
| 52 | A | Agilent Technologies, Inc. | Healthcare | $0.42B | $40.81B |
| 53 | ATR | AptarGroup, Inc. | Healthcare | $0.37B | $7.76B |
| 54 | MASI | Masimo Corporation | Healthcare | $0.36B | $9.42B |
| 55 | CRL | Charles River Laboratories International, Inc. | Healthcare | $0.36B | $13.29B |
| 56 | HALO | Halozyme Therapeutics, Inc. | Healthcare | $0.34B | $12.19B |
| 57 | OPCH | Option Care Health, Inc. | Healthcare | $0.31B | $3.54B |
| 58 | GMED | Globus Medical, Inc. | Healthcare | $0.30B | $10.01B |
| 59 | LNTH | Lantheus Holdings, Inc. | Healthcare | $0.30B | $6.58B |
| 60 | TFX | Teleflex Incorporated | Healthcare | $0.30B | $5.75B |
| 61 | HQY | HealthEquity, Inc. | Healthcare | $0.30B | $7.66B |
| 62 | BIO | Bio-Rad Laboratories, Inc. | Healthcare | $0.30B | $10.08B |
| 63 | COO | The Cooper Companies, Inc. | Healthcare | $0.29B | $12.38B |
| 64 | QGEN | Qiagen N.V. | Healthcare | $0.28B | $8.78B |
| 65 | STE | STERIS plc | Healthcare | $0.24B | $20.97B |
| 66 | GDRX | GoodRx Holdings, Inc. | Healthcare | $0.22B | $1.14B |
| 67 | GEHC | GE HealthCare Technologies Inc. | Healthcare | $0.20B | $29.44B |
| 68 | INSP | Inspire Medical Systems, Inc. | Healthcare | $0.18B | $1.92B |
| 69 | HAE | Haemonetics Corporation | Healthcare | $0.17B | $4.69B |
| 70 | CORT | Corcept Therapeutics Incorporated | Healthcare | $0.17B | $12.51B |
| 71 | VEEV | Veeva Systems Inc. | Healthcare | $0.17B | $42.23B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | $0.17B | $15.77B |
| 73 | NVST | Envista Holdings Corporation | Healthcare | $0.17B | $4.24B |
| 74 | EHC | Encompass Health Corporation | Healthcare | $0.16B | $11.99B |
| 75 | PBH | Prestige Consumer Healthcare Inc. | Healthcare | $0.16B | $2.31B |
| 76 | HUM | Humana Inc. | Healthcare | $0.15B | $48.03B |
| 77 | PCRX | Pacira BioSciences, Inc. | Healthcare | $0.15B | $1.03B |
| 78 | WST | West Pharmaceutical Services, Inc. | Healthcare | $0.13B | $23.71B |
| 79 | INMD | InMode Ltd. | Healthcare | $0.13B | $0.85B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | $0.13B | $15.66B |
| 81 | SLNO | Soleno Therapeutics, Inc. | Healthcare | $0.10B | $2.76B |
| 82 | SEM | Select Medical Holdings Corp | Healthcare | $0.10B | $2.05B |
| 83 | DVAX | Dynavax Technologies Corp | Healthcare | $0.10B | $1.76B |
| 84 | AUPH | Aurinia Pharmaceuticals Inc. | Healthcare | $0.10B | $2.16B |
| 85 | ARVN | Arvinas, Inc. | Healthcare | $0.09B | $0.57B |
| 86 | TGTX | TG Therapeutics, Inc. | Healthcare | $0.09B | $8.37B |
| 87 | HIMS | Hims & Hers Health, Inc. | Healthcare | $0.09B | $6.51B |
| 88 | CDNA | CareDx, Inc. | Healthcare | $0.09B | $2.59B |
| 89 | MD | Pediatrix Medical Group, Inc. | Healthcare | $0.09B | $2.20B |
| 90 | PGNY | Progyny, Inc. | Healthcare | $0.08B | $2.08B |
| 91 | OMCL | Omnicell, Inc. | Healthcare | $0.08B | $1.53B |
| 92 | AMPH | Amphastar Pharmaceuticals, Inc. | Healthcare | $0.08B | $0.98B |
| 93 | AVTR | Avantor, Inc. | Healthcare | $0.08B | $10.06B |
| 94 | ANAB | AnaptysBio, Inc. | Healthcare | $0.07B | $1.65B |
| 95 | HNGE | Hinge Health, Inc. | Healthcare | $0.07B | $7.37B |
| 96 | HCSG | Healthcare Services Group, Inc. | Healthcare | $0.06B | $1.51B |
| 97 | PODD | Insulet Corporation | Healthcare | $0.06B | $9.57B |
| 98 | ACHC | Acadia Healthcare Company, Inc. | Healthcare | $0.05B | $2.62B |
| 99 | ITGR | Integer Holdings Corporation | Healthcare | $0.05B | $4.28B |
| 100 | BBIO | BridgeBio Pharma, Inc. | Healthcare | $0.05B | $14.87B |
No companies match this search.
How this ranking is built
Companies are ranked by share buybacks as reported in their most recent annual filing with the SEC. Figures shown are in US dollars (or percent, as noted), rounded to two decimals.
- Source: annual 10-K / 20-F filings from companies trading on US exchanges (NYSE, Nasdaq, AMEX).
- Fiscal year: whichever annual period the company has most recently filed. Fiscal years don't always align with the calendar year, so the "as of FY" stamp above reflects the most common year across the table.
- Filtered out: warrants, preferred shares, and duplicate listings that share a parent company's financials.
- Size floor: A company qualifies at $500 million in market cap or above. Below that, one mis-stated figure outranks the companies the list is about.
- Currency check: A company whose annual revenue runs above 15 times its market cap is left out, because at that gap the two figures are not in the same currency.
- Currency check: A company whose balance sheet runs above 150 times its market cap is left out for the same reason.
- Update cadence: refreshed as companies file new annual reports (typically within 60–90 days of fiscal year end).
Not financial advice. This is a research tool, not a recommendation.